Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | Director | $10.4M | +$5M | +92.4% | May 16, 2024 |
DNA, DNABW | Ginkgo Bioworks Holdings, Inc. | Director | $619K | Jun 12, 2024 | ||
KRON | Kronos Bio, Inc. | Director | Jun 25, 2024 | |||
URGN | UroGen Pharma Ltd. | Director | Aug 6, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|